Houston

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic lymphocytic leukaemia1 trial
• Myelodysplastic syndromes1 trial

Phase

• Phase 32 trials

Status

• Recruiting2 trials

Lead sponsor

• Ascentage Pharma Group Inc.2 trials

Running trials

• Recruiting

  Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).

  NCT06641414· Phase 3· Ascentage Pharma Group Inc.· Source

  Contact: Guillermo Garcia-Manero, M.D. (principal investigator)

• Recruiting

  Global Trial in APG2575 for Patients With CLL/SLL

  NCT06104566· Phase 3· Ascentage Pharma Group Inc.· Source

  Contact: Nitin Jain, MD (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic lymphocytic leukaemia1 recruiting
• Myelodysplastic syndromes1 recruiting